Position in OCUL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,332,316
+$5,102,917 QoQ
Shares Held
950,338
+90.3% QoQ
Ownership
0.433%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 257 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,646,694,420 across 216 Biotechnology names. OCUL ranks #57 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in OCUL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,332,316 | 950,338 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $4,229,399 | 499,339 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,193,974 | 180,723 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,705,286 | 145,876 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,030,282 | 111,022 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $114,713 | 15,650 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $224,422 | 26,279 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $152,145 | 17,488 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $106,970 | 11,755 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $232,936 | 52,228 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $211,020 | 67,204 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $217,906 | 42,230 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $224,069 | 42,518 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $316,434 | 112,610 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $53,875 | 12,982 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $142,074 | 35,342 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $140,555 | 28,395 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $151,388 | 21,720 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $646,820 | 64,682 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $832,011 | 58,675 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,067,913 | 65,077 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,009,870 | 48,786 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $430,840 | 56,615 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $609,839 | 73,210 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||